1 unchanged sentence
Trading Arrangements
−Removed: During the three months ended March 31, 2024, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
+Added: During the three months ended June 30, 2024, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
Reference is made to the Index to Exhibits included herein.
80 unchanged sentences
10.1+ Amgen Inc.
−Removed: Amended and Restated 2009 Equity Incentive Plan.
+Added: Second Amended and Restated 2009 Equity Incentive Plan.
(Filed as Appendix C to the Definitive Proxy Statement on Schedule 14A on April 17, 2024 and incorporated herein by reference.)
−Removed: 10.1.1+ First Amendment to Amgen Inc.
−Removed: Amended and Restated 2009 Equity Incentive Plan, effective March 4, 2015.
−Removed: (Filed as an exhibit to Form 10-Q for the quarter ended March 31, 2015 on April 27, 2015 and incorporated herein by reference.)
−Removed: 10.1.2+ Second Amendment to Amgen Inc.
−Removed: Amended and Restated 2009 Equity Incentive Plan, effective March 2, 2016.
−Removed: (Filed as an exhibit to Form 10-Q for the quarter ended March 31, 2016 on May 2, 2016 and incorporated herein by reference.)
10.2+* Form of Grant of Stock Option Agreement for the Amgen Inc.
−Removed: Amended and Restated 2009 Equity Incentive Plan.
−Removed: (As Amended and Restated on December 11, 2023.) (Filed as an exhibit to Form 10-K for the year ended December 31, 2023 on February 14, 2024 and incorporated herein by reference.)
+Added: Second Amended and Restated 2009 Equity Incentive Plan.
+Added: (As Amended and Restated on May 31, 2024.)
10.3+* Form of Restricted Stock Unit Agreement for the Amgen Inc.
−Removed: Amended and Restated 2009 Equity Incentive Plan.
−Removed: (As Amended and Restated on December 11, 2023.) (Filed as an exhibit to Form 10-K for the year ended December 31, 2023 on February 14, 2024 and incorporated herein by reference.)
+Added: Second Amended and Restated 2009 Equity Incentive Plan.
+Added: (As Amended and Restated on May 31, 2024.)
10.4+* Amgen Inc.
2009 Performance Award Program.
−Removed: (As Amended on December 12, 2017.) (Filed as an exhibit to Form 10-K for the year ended December 31, 2017 on February 13, 2018 and incorporated herein by reference.)
+Added: (As Amended and Restated on May 31, 2024.)
10.5+* Form of Performance Unit Agreement for the Amgen Inc.
2009 Performance Award Program.
−Removed: (As Amended and Reinstated on December 11, 2023.) (Filed as an exhibit to Form 10-K for the year ended December 31, 2023 on February 14, 2024 and incorporated herein by reference.)
+Added: (As Amended and Restated on May 31, 2024.)
10.6+* Amgen Inc.
2009 Director Equity Incentive Program.
−Removed: (As Amended and Restated on October 24, 2023.) (Filed as an exhibit to Form 10-K for the year ended December 31, 2023 on February 14, 2024 and incorporated herein by reference.)
+Added: (As Amended and Restated on May 31, 2024.)
10.7+* Form of Restricted Stock Unit Agreement for the Amgen Inc.
2009 Director Equity Incentive Program.
−Removed: (As Amended on December 11, 2019.) (Filed as an exhibit to Form 10-K for the year ended December 31, 2019 on February 12, 2020 and incorporated herein by reference.)
−Removed: 10.8+ Form of Cash-Settled Restricted Stock Unit Agreement for the Amgen 2009 Director Equity Incentive Program.
−Removed: (As Amended on December 11, 2019.) (Filed as an exhibit to Form 10-K for the year ended December 31, 2019 on February 12, 2020 and incorporated herein by reference.)
+Added: (As Amended and Restated on May 31, 2024.)
+Added: 10.8+* Form of Cash-Settled Restricted Stock Unit Agreement for the Amgen Inc.
+Added: 2009 Director Equity Incentive Program.
+Added: (As Amended and Restated on May 31, 2024.)
10.9+ Amgen Inc.
29 unchanged sentences
(Filed as an exhibit to Form 10-K for the year ended December 31, 2021 on February 16, 2022 and incorporated herein by reference.)
−Removed: 10.12.4+ Fourth Amendment to the Amgen Nonqualified Deferred Compensation Plan, effective January 1, 2024 (Filed as an exhibit to Form 10-K for the year ended December 31, 2023 on February 14, 2024 and incorporated herein by reference.)
+Added: 10.12.4+ Fourth Amendment to the Amgen Nonqualified Deferred Compensation Plan, effective January 1, 2024 .
+Added: (Filed as an exhibit to Form 10-K for the year ended December 31, 2023 on February 14, 2024 and incorporated herein by reference.)
10.13+ Aircraft Time Sharing Agreement, dated December 3, 2021, by and between Amgen Inc.
82 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: May 2, 2024 By:
+Added: August 6, 2024 By:
/ S / PETER H.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.